{
    "id": "1242",
    "question": "A 28-year-old woman, gravida 1, para 0, at 20 weeks' gestation comes to the physician with her husband for a prenatal visit. Her pregnancy has been uncomplicated. They are planning to travel to Ethiopia next month to visit the husband's family. Medications include folic acid and an iron supplement. Vital signs are within the normal range. Abdominal examination shows a uterus that is consistent with a 20-week gestation. Which of the following drugs is most suitable for pre-exposure prophylaxis against malaria?",
    "options": {
        "A": "Doxycycline",
        "B": "Mefloquine",
        "C": "Chloroquine",
        "D": "Proguanil"
    },
    "answer": "B",
    "predict": "{\"step_by_step_thinking\": \"To determine the most suitable drug for pre-exposure prophylaxis against malaria in this patient, we need to consider several factors such as the patient's pregnancy status, the region she will be traveling to, and the specific malaria parasite prevalent in that region. In this case, the patient is at 20 weeks' gestation and is traveling to Ethiopia, which is a region with a high risk of malaria transmission. The patient is also taking folic acid and iron supplements, which are essential for her pregnancy. Given the patient's pregnancy status, we need to choose a medication that is safe for use during pregnancy. Doxycycline (A) is contraindicated in pregnancy due to the risk of inhibiting bone growth and causing tooth discoloration in the fetus. Chloroquine (C) is also not recommended for pregnant women due to the risk of retinal toxicity and other potential side effects. Proguanil (D) can be used during pregnancy, but it is typically used in combination with an antimalarial drug such as atovaquone or chloroquine. Mefloquine (B) is the most commonly recommended antimalarial medication for pregnant women, particularly for travelers to areas with a high risk of malaria transmission. However, it is essential to note that mefloquine has been associated with neuropsychiatric side effects, and its use should be carefully weighed against the benefits and risks. Considering the patient's pregnancy status and travel plans, mefloquine (B) is the most suitable option for pre-exposure prophylaxis against malaria, although its use should be discussed with the patient and her healthcare provider to weigh the benefits and risks.\"} \"answer_choice\": \"B\"",
    "snippets": [],
    "scores": [],
    "execution_time": 28.746078968048096
}